131 related articles for article (PubMed ID: 15488341)
1. Oral methylphenidate challenge selectively decreases putaminal T2 in healthy subjects.
Silveri MM; Anderson CM; McNeil JF; Diaz CI; Lukas SE; Mendelson JH; Renshaw PF; Kaufman MJ
Drug Alcohol Depend; 2004 Nov; 76(2):173-80. PubMed ID: 15488341
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum.
Chase T; Carrey N; Soo E; Wilkinson M
Neuroscience; 2007 Feb; 144(3):969-84. PubMed ID: 17156936
[TBL] [Abstract][Full Text] [Related]
3. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
Koochesfahani KM; de la Fuente-Fernández R; Sossi V; Schulzer M; Yatham LN; Ruth TJ; Blinder S; Stoessl AJ
Mov Disord; 2006 Jul; 21(7):970-5. PubMed ID: 16570297
[TBL] [Abstract][Full Text] [Related]
4. A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.
Spencer TJ; Bonab AA; Dougherty DD; Martin J; McDonnell T; Fischman AJ
Int J Mol Med; 2010 Feb; 25(2):261-5. PubMed ID: 20043136
[TBL] [Abstract][Full Text] [Related]
5. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain.
Chase TD; Carrey N; Brown RE; Wilkinson M
Brain Res Dev Brain Res; 2005 Apr; 156(1):1-12. PubMed ID: 15862622
[TBL] [Abstract][Full Text] [Related]
8. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate on basic and higher-order oculomotor functions.
Allman AA; Ettinger U; Joober R; O'Driscoll GA
J Psychopharmacol; 2012 Nov; 26(11):1471-9. PubMed ID: 22588495
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate hydrochloride increases energy expenditure in healthy adults.
Lorello C; Goldfield GS; Doucet E
Obesity (Silver Spring); 2008 Feb; 16(2):470-2. PubMed ID: 18239661
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults.
Kirschner J; Moll GH; Fietzek UM; Heinrich H; Mall V; Berweck S; Heinen F; Rothenberger A
Pharmacopsychiatry; 2003; 36(2):79-82. PubMed ID: 12734766
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs.
Bakhtiar R; Ramos L; Tse FL
Biomed Chromatogr; 2004 Jan; 18(1):45-50. PubMed ID: 14872548
[TBL] [Abstract][Full Text] [Related]
13. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.
Patrick KS; Straughn AB; Minhinnett RR; Yeatts SD; Herrin AE; DeVane CL; Malcolm R; Janis GC; Markowitz JS
Clin Pharmacol Ther; 2007 Mar; 81(3):346-53. PubMed ID: 17339864
[TBL] [Abstract][Full Text] [Related]
14. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment.
Silveri MM; Pollack MH; Diaz CI; Nassar LE; Mendelson JH; Yurgelun-Todd DA; Renshaw PF; Kaufman MJ
Psychiatry Res; 2004 Sep; 131(3):217-26. PubMed ID: 15465291
[TBL] [Abstract][Full Text] [Related]
15. Behavioral response to methylphenidate challenge: influence of early life parental care.
Engert V; Joober R; Meaney MJ; Hellhammer DH; Pruessner JC
Dev Psychobiol; 2009 Jul; 51(5):408-16. PubMed ID: 19492313
[TBL] [Abstract][Full Text] [Related]
16. DNA damage in rats after treatment with methylphenidate.
Andreazza AC; Frey BN; Valvassori SS; Zanotto C; Gomes KM; Comim CM; Cassini C; Stertz L; Ribeiro LC; Quevedo J; Kapczinski F; Berk M; Gonçalves CA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1282-8. PubMed ID: 17614179
[TBL] [Abstract][Full Text] [Related]
17. Stimulant-induced changes in smoking and caloric intake: influence of rate of onset.
Vansickel AR; Poole MM; Stoops WW; Hays KE; Upchurch MB; Glaser PE; Rush CR
Pharmacol Biochem Behav; 2009 Jun; 92(4):597-602. PubMed ID: 19281837
[TBL] [Abstract][Full Text] [Related]
18. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum.
Chase TD; Carrey N; Brown RE; Wilkinson M
Brain Res Dev Brain Res; 2005 Jun; 157(2):181-91. PubMed ID: 15916815
[TBL] [Abstract][Full Text] [Related]
20. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
